Food use
Food-use source coverage is present in the current record.
The ingredient appears in food-oriented source coverage or allowed-use references, which makes food use easier to support than a context with no domain signal at all.
EPA CPDat observed this chemical in 2753 composition records across product categories including Personal care, Laboratory supplies, Food and drug.
Concern score
The concern value is driven by the published classifications and regulatory status below — not by a single signal.
Concern score 45/100 (moderate) · high confidence.
Prevalence of POLYOXYL 40 STEARATE TYPE I in our catalog (epa_cpdat).
Products
2,753
Brands
6
Typical roles
Context-specific fit derived from published classifications and the current ingredient evidence profile.
Food use
Food-use source coverage is present in the current record.
The ingredient appears in food-oriented source coverage or allowed-use references, which makes food use easier to support than a context with no domain signal at all.
Fragrance avoidance
Not a strong fit for fragrance avoidance because it carries Fragrance.
Primary documents currently linked to this ingredient record.
Structured claim signals pulled from linked ingredient research.
Published jurisdiction-level classifications and regulatory designations for this ingredient.
US
EPA
EPA CPDat observed this chemical in 2753 composition records across product categories including Personal care, Laboratory supplies, Food and drug. EPA CPDat classifies this chemical for functional uses including Solvent, Surfactant (surface active agent), Cleaning agent.
US
FDA
Route: TOPICAL; Dosage form: CREAM; Maximum daily exposure: 552 mg
US
FDA
The ingredient itself is a fragrance-linked signal, so it is better treated as an avoid case when fragrance exposure is the main concern.
The published evidence profile currently shaping this ingredient record.
Route: TOPICAL; Dosage form: LOTION; Potency: 1 %w/w
US
FDA
Route: VAGINAL; Dosage form: CREAM; Maximum daily exposure: 100 mg
US
FDA
Route: ORAL; Dosage form: CONCENTRATE; Potency: 25 mg/5ml
US
FDA
Route: ORAL; Dosage form: SUSPENSION; Maximum daily exposure: 60 mg
US
FDA
Route: TOPICAL; Dosage form: CREAM; Maximum daily exposure: 229 mg
US
FDA
Route: AURICULAR (OTIC); Dosage form: SUSPENSION; Potency: 1 %w/v
US
FDA
Route: OPHTHALMIC; Dosage form: SOLUTION; Potency: 7 %w/w
US
FDA
Route: OPHTHALMIC; Dosage form: SUSPENSION; Potency: 0.5 %w/v
US
FDA
Route: ORAL; Dosage form: CAPSULE; Maximum daily exposure: 14 mg
US
FDA
Route: ORAL; Dosage form: TABLET, FILM COATED; Potency: 2 mg
US
FDA
Route: TOPICAL; Dosage form: AEROSOL, FOAM; Potency: 2.83 %w/w
US
FDA
Route: TOPICAL; Dosage form: CREAM; Maximum daily exposure: 50 mg
US
FDA
openFDA substance registry classifies this ingredient as polymer.
US
FDA
openFDA substance registry classifies this ingredient as mixture.